Page 2049 - Williams Hematology ( PDFDrive )

2024 Part XII: Hemostasis and Thrombosis <CN>: <ct> PB

393. Sarkar M, Mulliken JB, Kozakewich HP, et al: Thrombocytopenic coagulopathy (Kasa- 422. Zukerberg LR, Nickoloff BJ, Weiss SW: Kaposiform hemangioendothelioma of infancy
bach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome
not with common infantile hemangioma. Plast Reconstr Surg 100:1377–1386, 1997. and lymphangiomatosis. Am J Surg Pathol17:321–328, 1993.
394. Vin-Christian K, McCalmont TH, Frieden IJ: Kaposiform hemangioendothelioma. 423. George M, Singhal V, Sharma V, Nopper AJ: Successful surgical excision of a complex
An aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. vascular lesion in an infant with Kasabach-Merritt syndrome. Pediatr Dermatol 19:340–344,
Arch Dermatol 133:1573–1578, 1997. 2002.
395. Hall GW: Kasabach-Merritt syndrome: Pathogenesis and management. Br J Haematol 424. Balduini CL, Stella CC, Rosti V, et al: Acquired cyclic thrombocytopenia-thrombocyto-
112:851–862, 2001. sis with periodic defect of platelet function. Br J Haematol 85:718–722, 1993.
396. Cooper JG, Edwards SL, Holmes JD: Kaposiform haemangioendothelioma: Case report 425. Yujiri T, Tanaka Y, Tanaka M, Tanizawa Y: Fluctuations in thrombopoietin, immature
and review of the literature. Br J Plast Surg 55:163–165, 2002. platelet fraction, and glycocalicin levels in a patient with cyclic thrombocytopenia. Int J
397. Hoeger PH, Helmke K, Winkler K: Chronic consumption coagulopathy due to an occult Hematol 90:429–430, 2009.
splenic haemangioma: Kasabach-Merritt syndrome. Eur J Pediatr 154:365–368, 1995. 426. Go RS: Idiopathic cyclic thrombocytopenia. Blood Rev 19:53–59, 2005.
398. Brasanac D, Janic D, Boricic I, et al: Retroperitoneal kaposiform hemangioendothe- 427. Steensma DP, Harrison CN, Tefferi A: Hydroxyurea-associated platelet count oscilla-
lioma with tufted angioma-like features in an infant with Kasabach-Merritt syndrome. tions in polycythemia vera: A report of four new cases and a review. Leuk Lymphoma
Pathol Int 53:627–631, 2003. 42:1243–1253, 2001.
399. Mukhtar IA, Letts M: Hemangioma of the radius associated with Kasabach-Merritt 428. Abe Y, Hirase N, Muta K, et al: Adult onset cyclic hematopoiesis in a patient with mye-
syndrome: Case report and literature review. J Pediatr Orthop 24:87–91, 2004. lodysplastic syndrome. Int J Hematol 71:40–45, 2000.
400. Fukunaga M, Ushigome S, Ishikawa E: Kaposiform haemangioendothelioma associated 429. Aster RH, Bougie DW: Drug-induced immune thrombocytopenia. N Engl J Med
with Kasabach-Merritt syndrome. Histopathology 28:281–284, 1996. 357:580–587, 2007.
401. Alvarez-Mendoza A, Lourdes TS, Ridaura-Sanz C, Ruiz-Maldonado R: Histopathology 430. George JN, Raskob GE, Shah SR, et al: Drug-induced thrombocytopenia: A systematic
of vascular lesions found in Kasabach-Merritt syndrome: Review based on 13 cases. review of published case reports. Ann Intern Med 129:886–890, 1998.
Pediatr Dev Pathol 3:556–560, 2000. 431. Kaufman DW, Kelly JP, Johannes CB, et al: Acute thrombocytopenic purpura in relation
402. Jones EW, Orkin M: Tufted angioma (angioblastoma). A benign progressive angioma, to the use of drugs. Blood 82:2714–2718, 1993.
not to be confused with Kaposi’s sarcoma or low-grade angiosarcoma. J Am Acad 432. Garner SF, Campbell K, Metcalfe P, et al: Glycoprotein V: The predominant target anti-
Dermatol 20:214–225, 1989. gen in gold-induced autoimmune thrombocytopenia. Blood 100:344–346, 2002.
403. Wong SN, Tay YK: Tufted angioma: A report of five cases. Pediatr Dermatol 19:388–393, 433. Christie DJ, Mullen PC, Aster RH: Fab-mediated binding of drug-dependent antibod-
2002. ies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 75:
404. Mueller BU, Mulliken JB: The infant with a vascular tumor. Semin Perinatol 23:332–340, 310–314, 1985.
1999. 434. Lopez JA, Li CQ, Weisman S, Chambers M: The glycoprotein Ib-IX complex-specific
405. Mazoyer E, Enjolras O, Laurian C, et al: Coagulation abnormalities associated with monoclonal antibody SZ1 binds to a conformation-sensitive epitope on glycoprotein
extensive venous malformations of the limbs: Differentiation from Kasabach-Merritt IX: Implications for the target antigen of quinine/quinidine-dependent autoantibodies.
syndrome. Clin Lab Haematol 24:243–251, 2002. Blood 85:1254–1258, 1995.
406. Lyons LL, North PE, Mac-Moune LF, et al: Kaposiform hemangioendothelioma: A 435. Chong BH, Du XP, Berndt MC, Horn S, Chesterman CN: Characterization of the bind-
study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic unique- ing domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/
ness from juvenile hemangioma. Am J Surg Pathol 28:559–568, 2004. quinidine-dependent antibodies. Blood 77:2190–2199, 1991.
407. Gilon E, Ramot B, Sheba C: Multiple hemangiomata associated with thrombocytope- 436. Curtis BR, McFarland JG, Wu GG, Visentin GP, Aster RH: Antibodies in sulfon-
nia: Remarks on the pathogenesis of the thrombocytopenia in this syndrome. Blood amide-induced immune thrombocytopenia recognize calcium-dependent epitopes on
14:74–79, 1959. the glycoprotein IIb/IIIa complex. Blood 84:176–183, 1994.
408. Seo SK, Suh JC, Na GY, et al: Kasabach-Merritt syndrome: Identification of platelet 437. Visentin GP, Newman PJ, Aster RH: Characteristics of quinine- and quinidine-induced
trapping in a tufted angioma by immunohistochemistry technique using monoclonal antibodies specific for platelet glycoproteins IIb and IIIa. Blood 77:2668–2676, 1991.
antibody to CD61. Pediatr Dermatol 16:392–394, 1999. 438. Berkowitz SD, Harrington RA, Rund MM, Tcheng JE: Acute profound thrombocytope-
409. Brizel HE, Raccuglia G: Giant hemangioma with thrombocytopenia. Radioisotopic nia after C7E3 Fab (abciximab) therapy. Circulation 95:809–813, 1997.
demonstration of platelet sequestration. Blood 26:751–764, 1965. 439. Fiorin F, Steffan A, Pradella P, et al: IgG platelet antibodies in EDTA-dependent pseu-
410. Shulkin BL, Argenta LC, Cho KJ, Castle VP: Kasabach-Merritt syndrome: Treatment dothrombocytopenia bind to platelet membrane glycoprotein IIb. Am J Clin Pathol
with epsilon-aminocaproic acid and assessment by indium 111 platelet scintigraphy. J 110:178–183, 1998.
Pediatr 117:746–749, 1990. 440. Cancio LC, Cohen DJ: Heparin-induced thrombocytopenia and thrombosis. J Am Coll
411. Warrell RP Jr, Kempin SJ, Benua RS, et al: Intratumoral consumption of indium-111 Surg 186:76–91, 1998.
labeled platelets in a patient with hemangiomatosis and intravascular coagulation 441. Coblyn JS, Weinblatt M, Holdsworth D, Glass D: Gold-induced thrombocytopenia. A
(Kasabach-Merritt syndrome). Cancer 52:2256–2260, 1983. clinical and immunogenetic study of twenty-three patients. Ann Intern Med 95:178–181,
412. Wananukul S, Nuchprayoon I, Seksarn P: Treatment of Kasabach-Merritt syndrome: 1981.
A stepwise regimen of prednisolone, dipyridamole, and interferon. Int J Dermatol 42: 442. Nieminen U, Kekomaki R: Quinidine-induced thrombocytopenic purpura: Clinical
741–748, 2003. presentation in relation to drug-dependent and drug-independent platelet antibodies.
413. MacArthur CJ, Senders CW, Katz J: The use of interferon alfa-2a for life-threatening Br J Haematol 80:77–82, 1992.
hemangiomas. Arch Otolaryngol Head Neck Surg 121:690–693, 1995. 443. Leach MF, Cooper LK, AuBuchon JP: Detection of drug-dependent, platelet-reactive
414. Haisley-Royster C, Enjolras O, Frieden IJ, et al: Kasabach-Merritt phenomenon: A retro- antibodies by solid-phase red cell adherence assays. Br J Haematol 97:755–761, 1997.
spective study of treatment with vincristine. J Pediatr Hematol Oncol 24:459–462, 2002. 444. Visentin GP, Malik M, Cyganiak KA, Aster RH: Patients treated with unfractionated
415. Blei F, Karp N, Rofsky N, et al: Successful multimodal therapy for kaposiform heman- heparin during open heart surgery are at high risk to form antibodies reactive with
gioendothelioma complicated by Kasabach-Merritt phenomenon: Case report and heparin:platelet factor 4 complexes. J Lab Clin Med 128:376–383, 1996.
review of the literature. Pediatr Hematol Oncol 15:295–305, 1998. 445. Boon DM, van Vliet HH, Zietse R, Kappers-Klunne MC: The presence of antibodies
416. Hu B, Lachman R, Phillips J, et al: Kasabach-Merritt syndrome-associated kaposiform against a PF4-heparin complex in patients on haemodialysis. Thromb Haemost 76:480,
hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and 1996.
actinomycin D. J Pediatr Hematol Oncol 20:567–569, 1998. 446. Bauer TL, Arepally G, Konkle BA, et al: Prevalence of heparin-associated antibodies
417. Frevel T, Rabe H, Uckert F, Harms E: Giant cavernous haemangioma with Kasa- without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circula-
bach-Merritt syndrome: A case report and review. Eur J Pediatr 161:243–246, 2002. tion 95:1242–1246, 1997.
418. Atahan IL, Cengiz M, Ozyar E, Gurkaynak M: Radiotherapy in the management of 447. Gentilini G, Curtis BR, Aster RH: An antibody from a patient with ranitidine-induced
Kasabach-Merritt syndrome: A case report. Pediatr Hematol Oncol 18:471–476, 2001. thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for
419. Ogino I, Torikai K, Kobayasi S, et al: Radiation therapy for life- or function-threatening drug-induced antibodies. Blood 92:2359–2365, 1998.
infant hemangioma. Radiology 218:834–839, 2001. 448. Belkin GA: Cocktail purpura. An unusual case of quinine sensitivity. Ann Intern Med
420. Billio A, Pescosta N, Rosanelli C, et al: Treatment of Kasabach-Merritt syndrome by 66:583–586, 1967.
embolisation of a giant liver hemangioma. Am J Hematol 66:140–141, 2001. 449. Siroty RR: Purpura on the rocks—With a twist. JAMA 235:2521–2522, 1976.
421. Hosono S, Ohno T, Kimoto H, et al: Successful transcutaneous arterial embolization of 450. Pedersen-Bjergaard U, Andersen M, Hansen PB: Drug-induced thrombocytopenia:
a giant hemangioma associated with high-output cardiac failure and Kasabach-Merritt Clinical data on 309 cases and the effect of corticosteroid therapy. Eur J Clin Pharmacol
syndrome in a neonate: A case report. J Perinat Med 27:399–403, 1999. 52:183–189, 1997.

Kaushansky_chapter 117_p1993-2024.indd 2024 9/21/15 2:34 PM